Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C‐expressing lactobacilli
- 1 August 2000
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 100 (4) , 510-518
- https://doi.org/10.1046/j.1365-2567.2000.00069.x
Abstract
Summary: The delivery of antigens to mucosal‐associated lymphoid tissues in paediatric and immunocompromised populations by safe, non‐invasive vectors, such as commensal lactobacilli, represents a crucial improvement to prevailing vaccination options. In this report, we describe the oral and nasal immunization of mice with vaccines constructed through an original system for heterologous gene expression in Lactobacillus in which the 50 000‐molecular weight (MW) fragment C of tetanus toxin (TTFC) is expressed either as an intracellular or a surface‐exposed protein. Our data indicate that L. plantarum is more effective in this respect than L. casei and that, under the experimental conditions investigated, delivery of TTFC expressed as an intracellular antigen is more effective than cell‐surface expression. Immunization of mice with live recombinant lactobacilli induced significant levels of circulating TTFC‐specific immunoglobulin G (IgG) following nasal or oral delivery of vaccine strains. In addition, following nasal delivery, secretory immunoglobulin A (sIgA) was induced in bronchoalveolar lavage fluids, as were antigen‐specific antibody‐secreting cells and antigen‐specific T‐cell activation in draining lymph nodes, substantiating their potential for safe mucosal delivery of paediatric vaccines.Keywords
This publication has 25 references indexed in Scilit:
- Oral vaccination of mice against tetanus with recombinant Lactococcus lactisNature Biotechnology, 1997
- Nonlipopolysaccharide components) ofLactobacillus addophilusstimulate(s) the production of interleukin‐1α and tumor necrosis factor‐α by murine macrophagesNutrition and Cancer, 1997
- The potential of Lactobacillus as a carrier for oral immunization: Development and preliminary characterization of vector systems for targeted delivery of antigensJournal of Biotechnology, 1996
- Cytokine-inducing glycolipids in the lipoteichoic acid fraction fromEnterococcus hiraeATCC 9790FEMS Immunology & Medical Microbiology, 1995
- Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GGVaccine, 1995
- New strategies for using mucosal vaccination to achieve more effective immunizationVaccine, 1994
- Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strainsVaccine, 1993
- Construction of genetically defined double aro mutants of Salmonella typhiVaccine, 1991
- Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humansJournal of General Virology, 1990
- Therapeutic role of dietary lactobacilli and lactobacillic fermented dairy productsFEMS Microbiology Letters, 1987